Is your patient still using rosiglitazone?

dc.contributor.author	Gov-Ari, Hanna K.	eng
dc.contributor.author	Stevermer, James J.	eng
dc.contributor.other	Family Physicians Inquiries Network	eng
dc.date.issued	2011	eng
dc.description.abstract	Do not initiate rosiglitazone therapy for patients with diabetes, and consider switching those who are already taking it to pioglitazone. Stength of recommendation: A: Based on a meta-analysis of 56 randomized trials.	eng
dc.identifier.uri	http://hdl.handle.net/10355/10727
dc.language	English	eng
dc.publisher	Family Physicians Inquiries Network	eng
dc.relation.ispartofcollection	Priority Updates to Research Literature (PURLs) (2011)	eng
dc.relation.ispartofcommunity	University of Missouri-Columbia. School of Medicine. Department of Family and Community Medicine. Family Physicians Inquiries Network	eng
dc.relation.ispartofseries	Journal of family practice, 60, no. 05 (May 2011): 282-284.	eng
dc.rights	OpenAccess.	eng
dc.rights.license	This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License.	eng
dc.subject.lcsh	Non-insulin-dependent diabetes	eng
dc.subject.lcsh	Diabetes -- Research	eng
dc.subject.lcsh	Diabetes -- Therapeutics -- Complications	eng
dc.subject.other	Type 2 diabetes	eng
dc.subject.other	Rosiglitazone	eng
dc.subject.other	Pioglitazone	eng
dc.title	Is your patient still using rosiglitazone?	eng
dc.type	Article	eng

Priority Updates to Research Literature (PURLs)
Priority Updates to Research Literature generate new evidence-based recommendations for practice for family physicians and other primary care clinicians.